- 专利标题: Method of treating Rett syndrome by oral administration of acetate which is provided as composition comprising magnesium acetate, calcium acetate or ethylacetate
-
申请号: US15251880申请日: 2016-08-30
-
公开(公告)号: US09968580B2公开(公告)日: 2018-05-15
- 发明人: David Michael Ott
- 申请人: David Michael Ott
- 主分类号: A61K31/32
- IPC分类号: A61K31/32 ; A23L33/10 ; A61K31/19 ; A61K31/22
摘要:
Genetic and epigenetic diseases and disorders are treated with FDA approved dietary compositions in the form of dietary supplements and nutraceuticals. The diseases and disorders to be treated include Rett syndrome, trinucleotide repeat diseases such as Fragile X syndrome, memory impairment, chronic inflammation, pre-cancerous conditions which involve cancer stem cells, and post-cancerous conditions which involve cancer stem cells which have survived in spite of cancer treatment. Treatment options include prophylactic treatment which is initiated prior to the development of the symptoms of the disease or disorder.
公开/授权文献
信息查询